Sichuan Kelun Pharmaceutical Co (SZSE:002422) LT-Debt-to-Total-Asset : 0.04 (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Sichuan Kelun Pharmaceutical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Sichuan Kelun Pharmaceutical Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.04.

Sichuan Kelun Pharmaceutical Co's long-term debt to total assets ratio declined from Mar. 2023 (0.11) to Mar. 2024 (0.04). It may suggest that Sichuan Kelun Pharmaceutical Co is progressively becoming less dependent on debt to grow their business.

Sichuan Kelun Pharmaceutical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Sichuan Kelun Pharmaceutical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Kelun Pharmaceutical Co LT-Debt-to-Total-Asset Chart

Sichuan Kelun Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.07

0.16

0.11

0.14

0.08

Sichuan Kelun Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.11	0.10	0.10	0.08	0.04

Sichuan Kelun Pharmaceutical Co LT-Debt-to-Total-Asset Calculation

Sichuan Kelun Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	2893.814	/	36454.901
	=	0.08

Sichuan Kelun Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	1553.439	/	37676.458
	=	0.04

Sichuan Kelun Pharmaceutical Co (SZSE:002422) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Sichuan Kelun Pharmaceutical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun Pharmaceutical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.36 West Baihua Road, Qingyang District, Chengdu, CHN, 610071

Website

http://www.kelun.com

Sichuan Kelun Pharmaceutical Co Ltd is a China-based Pharmaceutical company mainly focused on the production and sales of injection products, including products for glucose injection and sodium chloride injection. It manufactures and sells high-volume injections (infusions), small-volume injections (water needles), sterile powder injections (containing powdered and freeze-dried powder). Its products include tablets, capsules, capsules, granules, oral liquids, peritoneal dialysis fluids, raw material medicines, medical packaging materials, medical instruments, and antibiotic intermediates.

Executives

Lai De Gui	Executives
Feng Hao	Directors, executives
Liu Si Chuan	Directors, executives
Wang Jing Yi	Directors, executives
Wan Yang Yu	Executives
Ge Jun You	Executives
Wu Zhong Hua	Executives
Wan Peng	Supervisors
Tan Hong Bo	Executives
Liu Ge Xin	Director
Huang Xin	Securities Affairs Representative
Ge Tao	Executives
Pan Hui	Directors, executives
Zhou Xiao Dong	Executives
Zheng Chang Yan	Supervisors

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Headlines

No Headlines